Formula F9, Papaverine 0.9 mg/mL, Phentolamine 0.1 mg/mL, PGE 20 mcg/mL, Atropine 0.01 mg/mL, Mul...

FDA Drug Recall #D-0720-2022 — Class III — March 8, 2022

Recall Summary

Recall Number D-0720-2022
Classification Class III — Low risk
Date Initiated March 8, 2022
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Olympia Compounding Pharmacy dba Olympia Pharmacy
Location Orlando, FL
Product Type Drugs
Quantity 493 vials.

Product Description

Formula F9, Papaverine 0.9 mg/mL, Phentolamine 0.1 mg/mL, PGE 20 mcg/mL, Atropine 0.01 mg/mL, Multi-Dose 10 mL vial, Each ML contains: 0.5% Chlorobutanol NF, 0.005% Edetate Disodium Dihydrate USP, 2.74% Benzyl Alcohol NF, 5% Mannitol USP, 1% Sodium Metabisulfite NF, 1% Ethyl Alcohol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0004-10

Reason for Recall

Sub Potent

Distribution Pattern

Nationwide in the USA including Puerto Rico.

Lot / Code Information

Lot: D41C19 Exp. 4/19/22

Other Recalls from Olympia Compounding Pharmacy dba Olym...

Recall # Classification Product Date
D-0904-2022 Class II Sodium Bicarbonate 8.4% MDV Injection, Multi-Do... May 9, 2022
D-0930-2022 Class II Lidocaine 2% (20 mg/mL), Multi-Dose 30 mL vial ... May 9, 2022
D-0910-2022 Class II T-106 Papaverine 30 mg/mL Phentolamine 1 mg/mL ... May 9, 2022
D-0905-2022 Class II Sodium Selenite 200 mg/mL, Multi-Dose 30 mL via... May 9, 2022
D-0902-2022 Class II Sermorelin Acetate Lyophilized powder for recon... May 9, 2022

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.